Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Arterial Hypertension (PAH)

Clinical trial condition

Pulmonary Arterial Hypertension (PAH)

Explore clinical trials studying Pulmonary Arterial Hypertension (PAH). Study availability and eligibility vary by location and protocol.

42 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension (PAH) trial results

Not Yet Recruiting

Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07632898

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations

NCT07612657

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)

NCT07601295

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: The University of Arizona / Banner University Medical Center Tucson, Arizona, United States

University of California, San Francisco San Francisco, California, United States

Stanford University Stanford, California, United States

University of Colorado (UCD) Anschutz Aurora, Colorado, United States

View Trial Details

Not Yet Recruiting

Development and Validation of a Chinese Quality of Life Scale for Pulmonary Arterial Hypertension

NCT07570615

Conditions: Hypertension, Pulmonary, Lung Diseases, Patients Reported Outcomes, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.

NCT07487441

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +6 more
Locations: The Clinical and Translational Sciences Research Center Tucson, Arizona, United States

View Trial Details

Not Yet Recruiting

Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension

NCT07453030

Conditions: Helminthiasis, Hypertension, Pulmonary, Infections, +8 more
Locations: Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo São Paulo, Brazil

View Trial Details

Not Yet Recruiting

Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension

NCT07356375

Conditions: Behavior, Health Behavior, Hypertension, Pulmonary, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension

NCT07368088

Conditions: Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pulmonary, Lung Diseases, +9 more
Locations: Samsung Medical Center, 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea

View Trial Details

Not Yet Recruiting

Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension

NCT07314814

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: University Hospitals Geneva / University of Geneva Geneva, Canton of Geneva, Switzerland

View Trial Details

Not Yet Recruiting

SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

NCT07266519

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: Not specified

View Trial Details